# Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

> **NCT04742907** · PHASE2 · COMPLETED · sponsor: **Tsumura USA** · enrollment: 402 (actual)

## Conditions studied

- Enhanced Recovery After Surgery

## Interventions

- **DRUG:** TU-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04742907
- **Lead sponsor:** Tsumura USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-05-01
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742907, "Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04742907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*